Skip to main content
. 2018 May 16;16(1):1173–1179. doi: 10.3892/ol.2018.8719

Figure 1.

Figure 1.

MEF2D is expressed at a high level in lung cancer tissue samples. (A) Immunohistochemical analysis of the expression of MEF2D was performed in tumor and paired non-cancerous tissues. (B) Western blot analysis of the protein expression of MEF2D in lung cancer and paired non-cancerous tissue. Quantification of western blots is shown below corresponding bands. (C) Reverse transcription-quantitative polymerase chain reaction analysis of mRNA levels of MEF2D in paired patient cancer and normal tissues. MEF2D, myocyte enhancer factor 2D; T, tumor; N, non-cancerous.